The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
BL-B01D1, a first-in-class EGFRxHER3 bispecific antibody-drug conjugate (ADC), in patients with locally advanced or metastatic solid tumor: Results from a first-in-human phase 1 study.
 
Li Zhang
Consulting or Advisory Role - AstraZeneca; Innovent Biologics
Speakers' Bureau - AstraZeneca; BeiGene; HenRui; Innovent Biologics; Roche China
Research Funding - Akeso Biopharma (Inst); AstraZeneca (Inst); BMS (Inst); Chia Tai Tianqing Pharmaceutical Group (Inst); Junshi Pharmaceuticals (Inst); QiLu Pharmaceutical (Inst)
 
Yuxiang Ma
No Relationships to Disclose
 
Yuanyuan Zhao
No Relationships to Disclose
 
Wenfeng Fang
No Relationships to Disclose
 
Hongyun Zhao
No Relationships to Disclose
 
Yan Huang
No Relationships to Disclose
 
Yunpeng Yang
Research Funding - AstraZeneca; Lilly O.
 
Likun Chen
No Relationships to Disclose
 
Xue Hou
No Relationships to Disclose
 
Wen Zou
Employment - Baili Biopharmaceutical
 
Muran Ding
Employment - Baili Biopharmaceutical; Baili Biopharmaceutical
 
Jing Yu
Employment - Baili Biopharmaceutical
 
Suoyu Zhang
Employment - Baili Biopharmaceutical
 
Junxian Wang
Employment - Baili Biopharmaceutical
 
Sa Xiao
Employment - Baili Biopharmaceutical
Stock and Other Ownership Interests - Baili Biopharmaceutical
 
Hongwei Wang
No Relationships to Disclose
 
Hai Zhu
Employment - Baili Biopharmaceutical (I); Systimmune; Systimmune (I)
Leadership - Baili Biopharmaceutical (I); Systimmune (I)
Stock and Other Ownership Interests - Baili Biopharmaceutical (I); Systimmune; Systimmune (I)
 
Martin Sebastian Olivo
Employment - Gilead Sciences; Protara Therapeutics; Systimmune
Leadership - Protara Therapeutics; Systimmune
Stock and Other Ownership Interests - Gilead Sciences; Protara Therapeutics; SystImmune
(OPTIONAL) Uncompensated Relationships - Phoenix Molecular Designs
 
Yi Zhu
Employment - Baili Biopharmaceutical; SystImmune; Systimmune (I)
Leadership - Baili Biopharmaceutical; SystImmune
Stock and Other Ownership Interests - Baili Biopharmaceutical; SystImmune; SystImmune (I)